Insulinsezernierende Zellen zur Therapie des Diabetes mellitus
Publication
, Journal Article
Schnedl, WJ; Hohmeier, HE; Newgard, CB
Published in: Naturwissenschaften
December 1, 1996
Even with intensive insulin therapy it is impossible to reach physiological blood glucose levels in insulin-dependent diabetes mellitus. Because of the high costs and technical problems involved in islet cell transplantation broad applicability of this therapy seems uncertain. An alternative approach is the development of molecular-engineered insulin-producing clonal cell lines. The main interest is in rodent insulinoma cell lines and neuroendocrine AtT-20ins cells. This paper reviews the current knowledge about glucose-stimulated insulin secretion and the problems that have to be solved before these cells can be used for therapy in diabetes mellitus.
Duke Scholars
Published In
Naturwissenschaften
ISSN
0028-1042
Publication Date
December 1, 1996
Volume
83
Issue
1
Start / End Page
1 / 5
Related Subject Headings
- General Science & Technology
Citation
APA
Chicago
ICMJE
MLA
NLM
Schnedl, W. J., Hohmeier, H. E., & Newgard, C. B. (1996). Insulinsezernierende Zellen zur Therapie des Diabetes mellitus. Naturwissenschaften, 83(1), 1–5.
Schnedl, W. J., H. E. Hohmeier, and C. B. Newgard. “Insulinsezernierende Zellen zur Therapie des Diabetes mellitus.” Naturwissenschaften 83, no. 1 (December 1, 1996): 1–5.
Schnedl WJ, Hohmeier HE, Newgard CB. Insulinsezernierende Zellen zur Therapie des Diabetes mellitus. Naturwissenschaften. 1996 Dec 1;83(1):1–5.
Schnedl, W. J., et al. “Insulinsezernierende Zellen zur Therapie des Diabetes mellitus.” Naturwissenschaften, vol. 83, no. 1, Dec. 1996, pp. 1–5.
Schnedl WJ, Hohmeier HE, Newgard CB. Insulinsezernierende Zellen zur Therapie des Diabetes mellitus. Naturwissenschaften. 1996 Dec 1;83(1):1–5.
Published In
Naturwissenschaften
ISSN
0028-1042
Publication Date
December 1, 1996
Volume
83
Issue
1
Start / End Page
1 / 5
Related Subject Headings
- General Science & Technology